Characteristics of HBV Novel Serum Markers across Distinct Phases in Treatment-Naïve Chronic HBV-Infected Patients.

Dis Markers · 2022 · PMC9303147 · PMID 35872701

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

In HBeAg-positive patients, IT-phase patients had higher serum HBcrAg levels than IC-phase patients, and the difference was marginally significant [8.91(8.42, 9.07) vs. 8.66 (8.21, 8.93) log 10 U/mL, P = 0.055], while in HBeAg-negative patients, LR-phase patients had lower HBcrAg levels than reactivation-phase patients [3.31 (3.05, 4.56) vs. 2.70 (2.15, 3.18) log 10 U/mL, P = 0.012].

also in 26,082 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.